Setmelanotide
Open-Label Extension Study of Setmelanotide
Rhythm · Phase 3 · Completed · Enrollment 28
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Setelanotide (Open-label) | n/r | n/r | n/r | n/r |
Not shown
- Setelanotide (Open-label): endpoint not reported